The catalytic cysteine of islet antigen 2 is crucial to autoantibody binding in type 1 diabetes

被引:0
|
作者
Elvers, K. T. [1 ]
Broadhurst, J. W. [1 ]
Easton, P. R. [1 ]
Lampasona, V. [2 ]
Bingley, P. J. [1 ]
Williams, A. J. K. [1 ]
机构
[1] Univ Bristol, Bristol BS8 1TH, Avon, England
[2] Ctr Genom Bioinformat & Biostat, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
431
引用
收藏
页码:S178 / S179
页数:2
相关论文
共 50 条
  • [21] Islet Cell Autoantibody Reactivity on Pancreatic Tissue from Donors with Type 1 Diabetes
    Rowe, Patrick
    Posgai, Amanda L.
    Campbell-Thompson, Martha
    Wasserfall, Clive
    Martino, Maria Fernanda
    Albanese-O'Neil, Anastasia
    Schatz, Desmond
    Atkinson, Mark
    [J]. DIABETES, 2011, 60 : A669 - A669
  • [22] Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering
    Mistry, Sejal
    Gouripeddi, Ramkiran
    Raman, Vandana
    Facelli, Julio C.
    [J]. DIABETOLOGIA, 2023, 66 (03) : 520 - 534
  • [23] Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
    Kwon, Bum Chul
    Achenbach, Peter
    Anand, Vibha
    Frohnert, Brigitte I.
    Hagopian, William
    Hu, Jianying
    Koski, Eileen
    Lernmark, Ake
    Lou, Olivia
    Martin, Frank
    Ng, Kenney
    Toppari, Jorma
    Veijola, Riitta
    [J]. DIABETES, 2022, 71 (12) : 2632 - 2641
  • [24] Islet autoantibody TypesMark differential clinical characteristics at diagnosis of pediatric type 1 diabetes
    Nieto, Jacob
    Castillo, Beatriz
    Astudillo, Marcela
    Tosur, Mustafa
    Balasubramanyam, Ashok
    Pietropaolo, Massimo
    Redondo, Maria J.
    [J]. PEDIATRIC DIABETES, 2021, 22 (06) : 882 - 888
  • [25] Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
    Piemonti, Lorenzo
    Everly, Matthew J.
    Maffi, Paola
    Scavini, Marina
    Poli, Francesca
    Nano, Rita
    Cardillo, Massimo
    Melzi, Raffaella
    Mercalli, Alessia
    Sordi, Valeria
    Lampasona, Vito
    de Arias, Alejandro Espadas
    Scalamogna, Mario
    Bosi, Emanuele
    Bonifacio, Ezio
    Secchi, Antonio
    Terasaki, Paul I.
    [J]. DIABETES, 2013, 62 (05) : 1656 - 1664
  • [26] Islet autoantibody qualification for optimising trial design type 1 diabetes prevention studies
    O'Doherty, I.
    Burton, J.
    Hedrick, J.
    Lernmark, A.
    Podichetty, J.
    Romero, K.
    Dunne, J. L.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S176 - S177
  • [27] Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes
    Ziegler, A. -G.
    Bonifacio, E.
    [J]. DIABETOLOGIA, 2012, 55 (07) : 1937 - 1943
  • [28] Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering
    Sejal Mistry
    Ramkiran Gouripeddi
    Vandana Raman
    Julio C. Facelli
    [J]. Diabetologia, 2023, 66 : 520 - 534
  • [29] Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals with Presymptomatic Type 1 Diabetes
    Kwon, Bum Chul
    Achenbach, Peter
    Anand, Vibha
    Hagopian, William
    Hu, Jianying
    Koski, Eileen
    Lernmark, Ake
    Ng, Kenney
    Toppari, Jorma
    Veijola, Riitta
    Frohnert, Brigitte I.
    [J]. DIABETES, 2022, 71
  • [30] Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics
    Grace, Sian Louise
    Bowden, Jack
    Walkey, Helen C.
    Kaur, Akaal
    Misra, Shivani
    Shields, Beverley M.
    McKinley, Trevelyan J.
    Oliver, Nick S.
    McDonald, Timothy
    Johnston, Desmond G.
    Jones, Angus G.
    Patel, Kashyap A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (12): : E4341 - E4349